The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Andrew Young is an influential leader in the biotechnology sector, serving as the CEO and Managing Partner of Conjugate Group ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

A new ML-guided platform can design thousands of new enzymes, predict how they will behave in the real world, and test their ...

Azzur Cleanrooms on Demand (COD) has entered this acronym-laden environment to provide cleanroom and laboratory spaces for so-called GxP manufacturing support. Opened in May 2023, it’s a 75,000-square ...

A former Colorado Bureau of Investigation forensic scientist accused of mishandling DNA and impacting more than 1,000 cases ...

Kassa and others said Big Pharma continues to invest even as private equity funds have pulled back. He noted ...

Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...

Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in ...

"Real-time analytics is more than just a tool—it’s a paradigm shift," says Dr. Aditya Dodda, an expert in building real-time ...

A study has introduced a novel bioprocess that transforms CO2 and electricity into single-cell protein (SCP), a sustainable ...